Delaet Ingrid 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Jul 11, 2025
Insider Transaction Report
Form 4
Delaet Ingrid
Chief Regulatory Officer
Transactions
- Exercise/Conversion
Non-Qualified Stock Option
2025-07-10−457→ 2,261 totalExercise: $79.02Exp: 2032-01-31→ Common Stock (457 underlying) - Sale
Common Stock
2025-07-10$135.00/sh−457$61,695→ 4,730 total - Exercise/Conversion
Common Stock
2025-07-10$79.02/sh+457$36,112→ 5,187 total
Footnotes (2)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023.
- [F2]The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032.